Company Profile
Updated: 26-OCT-09AstraZeneca GmbH
International Private company
Tinsdaler Weg 183, Wedel, D-22880, Germany
()49 04103 7 08 0, 49 04103 7 08 32 93 fax, http://www.astrazeneca.de
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture and sale of pharmaceuticals
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research and Markets Adds Report: Commercial Insight: Antidiabetics in Australia.
Health & Beauty Close-Up; 11/17/2009; 844 words; ...product will not regain market share before its patent expiry. Companies Mentioned: - Alphapharm - AstraZeneca PLC - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Deakin University - Eli Lilly and Company - IMS Health - Novo Nordisk...
Research and Markets Adds Report: Pipeline Insight: Colorectal Cancer.
Health & Beauty Close-Up; 11/17/2009; 871 words; ...generating GBP604m by 2018 in the seven major pharmaceutical markets. Companies Mentioned: - AstraZeneca PLC - Biogen Idec, Inc. - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Eli Lilly and Company - Genentech, Inc. - Human Genome...
Research and Markets: Commercial Insight: Antidiabetics in Australia - Reimbursement Status Shapes Novel Classes.
Business Wire; 11/11/2009; 761 words; ...Chapter 5 Case Study - The Process From Tga Approval To Pbs Listing Companies Mentioned: * Alphapharm * AstraZeneca PLC * Boehringer Ingelheim GmbH * Bristol-Myers Squibb Company * Deakin University * Eli Lilly and Company * IMS Health * Novo Nordisk...
Commercial Insight: Antidiabetics in Australia - Reimbursement Status Shapes Novel Classes.
M2 Presswire; 11/11/2009; 800 words; ...Chapter 5 Case Study - The Process From Tga Approval To Pbs Listing Companies Mentioned: - Alphapharm - AstraZeneca PLC - Boehringer Ingelheim GmbH - Bristol-Myers Squibb Company - Deakin University - Eli Lilly and Company - IMS Health - Novo Nordisk...
DPP-IV Inhibitor Data Abound As Januvia Competition Draws Near.
BIOWORLD Today; 11/3/2009; 2348 words; ...Phase III is saxagliptin, from Bristol-Myers Squibb Co. and AstraZeneca plc. Data from a 743-patient trial presented at ADA showed...DPP-IV inhibition. The German firm Boehringer Ingleheim GmbH presented posters from several clinical trials showing that...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
